Delivery Order SPE2DB24D8003-SPE2DB24FJTLA

Award Date 8/28/24
Potential Completion Date 8/29/24
Potential Value $1.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $4,978.01 firm fixed-price contract is for the delivery of VEMLIDY 25 MG TABLET UU 30S, a pharmaceutical product, to support U.S. Armed Forces medical operations. The contract has an ultimate completion date of November 5, 2024. Dakota Drug, Inc. holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT...
This is a delivery order contract (SPE2DB24D8002/SPE2DB25FJNCT) awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of pharmaceutical products, medical supplies, and healthcare equipment. The contract has a ceiling value of $10,364.55 and a completion date of February 10, 2025. Dakota Drug, Inc. is a key supplier for the DLA Troop Support Medical division, holding a $999,999,999.00 Indefinite Delivery Contract (IDC)...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $1,789.32 to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of TRINTELLIX 5 MG TABLET 30S, a pharmaceutical product, with a period of performance through September 24, 2024. This delivery order is placed under Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, identified as SPE2DB24D8001 and...
The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a delivery order contract to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $2,073.16 firm fixed-price contract is for the delivery of 100 units of the prescription medication Vyvanse 40 mg capsules. This award falls under Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract has a ceiling value of $7,921.62 and a period of performance through May 3, 2024. It is a firm fixed-price contract for the delivery of pharmaceutical products and medical supplies, including varenicline starting month boxes, to support U.S. Armed Forces medical operations. Dakota Drug, Inc....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of VYVANSE 20 MG CAPSULE 100S, a pharmaceutical product. The total ceiling value of the contract is $2,777.10, with a period of performance through March 18, 2025. This contract is not set-aside and is a firm fixed-price delivery order. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $3,101.32 firm fixed price contract is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of January 6, 2025. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, that enables the company to provide...
This is a delivery order contract awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) for the procurement of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML pharmaceutical products. The contract has a ceiling value of $1,550.66 and a period of performance through December 16, 2024. It is a firm fixed-price contract, with no set-aside designation. Dakota Drug, Inc. is a key supplier to the DLA's Troop Support Medical division, providing a wide range...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of PROQUAD VIALS, a medical product, and has a ceiling value of $5,758.90. The contract is a Firm Fixed Price, Delivery Order type, with a period of performance through September 19, 2024. Dakota Drug, Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA, identified as...
This federal contract award, valued at $6,467.31, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The contract is a firm fixed-price delivery order for the provision of 4565365894 ! YUVAFEM 10 MCG VAGINAL INSERT 18S. Dakota Drug, Inc. holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA under the ECAT Generation V Program, which enables the...
  • SPE2DB24D8003
    Indefinite Delivery Contract
  • SPE2DB24D8003-SPE2DB24FJTLA
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of the pharmaceutical product Viibryd 20 mg tablets, with a ceiling value of $1,309.00 and a period of performance through August 29, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation.

Dakota Drug, Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive range of pharmaceutical products, medical supplies, and healthcare equipment to support U.S. Armed Forces medical operations under the DLA Troop Support Medical's ECAT Generation V Program. This positions Dakota Drug, Inc. as a key supplier for the DLA's military medical supply programs.

Generated 11/27/24, 9:21 AM